Holdings
Novo Holdings A/S
As of Sep 30, 2026, Novo Holdings A/S reported 26 positions worth US$1.46B. Largest: Edgewise Therapeutics, Inc., ASML Holding NV and Brookfield Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Edgewise Therapeutics, Inc. | 5.35M | US$217M | no change | Sep 30, 2026 |
| ASML Holding NV | 94,946 | US$172M | no change | Sep 30, 2026 |
| Brookfield Corporation | 4.47M | US$163M | +969K | Sep 30, 2026 |
| Hemab Therapeutics Holdings, Inc. | 4.18M | US$129M | no change | Sep 30, 2026 |
| Avalyn Pharma Inc. | 3.45M | US$98.3M | −434K | Sep 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 1.13M | US$96.2M | no change | Sep 30, 2026 |
| Salesforce, Inc. | 393K | US$90.3M | no change | Sep 30, 2026 |
| Enliven Therapeutics, Inc. | 1M | US$45.8M | no change | Sep 30, 2026 |
| 4D Molecular Therapeutics, Inc. | 3M | US$42.9M | −249K | Sep 30, 2026 |
| Obsidian Therapeutics, Inc. | 3.12M | US$42.9M | new | Sep 30, 2026 |